Prostate cancer: Predicting response to androgen receptor signalling inhibition
- PMID: 25048863
- DOI: 10.1038/nrurol.2014.179
Prostate cancer: Predicting response to androgen receptor signalling inhibition
Comment on
-
Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer.Eur Urol. 2015 Jan;67(1):53-60. doi: 10.1016/j.eururo.2014.05.005. Epub 2014 May 29. Eur Urol. 2015. PMID: 24882673 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical